Medicines Act Notices




NEW ZEALAND GAZETTE

No. 66

1530

Health

Medicines Act 1981

Consent to the Distribution of a New Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Beclomethasone dipropionate 50 µg, 100 µg, 250 µg Inhaler, aerosol. Metered Norton (Waterford) Limited, Waterford Industrial Estate, Waterford, Eire Beclazone Inhaler
Beclomethasone dipropionate 50 µg, 100 µg, 250 µg Inhaler, aerosol. Metered Norton (Waterford) Limited, Waterford Industrial Estate, Waterford, Eire Beclazone Easi-Breathe Inhaler

Dated this 30th day of April 1998.

G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.

go3240

Consent to the Distribution of a New Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Flucloxacillin 250 mg, 500 mg Capsule Athlone Laboratories Limited, Ballymurray, Roscommon, Eire HSS-Flucloxacillin

Dated this 30th day of April 1998.

G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.

go3280

Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act, are set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Fentanyl citrate 25 µg/hour, 50 µg/hour, 75 µg/hour, 100 µg/hour Transdermal patch Alza Corporation, Vacaville, California, United States of America Durogesic
Nicotine 10 mg Inhalation, volatile liquid Pharmacia AB., Helsingborg, Sweden Nicorette Inhaler

Dated this 7th day of May 1998.

G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.

go3297

Consent to the Distribution of a New Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Candesartan cilexetil 4 mg, 8 mg, 16 mg Tablet Astra Pharmaceutical Production AB., Södertälje, Sweden Atacand


Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa PDF NZ Gazette 1998, No 66


NZLII PDF NZ Gazette 1998, No 66





✨ LLM interpretation of page content

🏥 Consent to the Distribution of a New Medicine

🏥 Health & Social Welfare
30 April 1998
Medicines, Distribution, Beclomethasone dipropionate, Inhaler
  • G. R. Boyd, Chief Advisor, Regulation and Safety

🏥 Consent to the Distribution of a New Medicine

🏥 Health & Social Welfare
30 April 1998
Medicines, Distribution, Flucloxacillin, Capsule
  • G. R. Boyd, Chief Advisor, Regulation and Safety

🏥 Consent to the Distribution of Changed Medicines

🏥 Health & Social Welfare
7 May 1998
Medicines, Distribution, Fentanyl citrate, Nicotine, Transdermal patch, Inhalation
  • G. R. Boyd, Chief Advisor, Regulation and Safety

🏥 Consent to the Distribution of a New Medicine

🏥 Health & Social Welfare
7 May 1998
Medicines, Distribution, Candesartan cilexetil, Tablet
  • G. R. Boyd, Chief Advisor, Regulation and Safety